[www.rhodium.ws] [] [Chemistry Archive]
 
 

Impurities in illicit drug preparations:
3,4-MethylenedioxyAmphetamine and
3,4-MethylenedioxyMethylamphetamine

A.M.A. Verweij
Forensic. Sci. Rev. 4,137-146 (1992)

HTML by Rhodium

Abstract

Attention is given here to the mass spectral data of impurities present in illicit drug preparations of 3,4-(methylenedioxy)amphetamine and 3,4-(methylenedioxy)- methylamphetamine. These "designer" drugs, having emphatic properties, were synthesized following well-known procedures such as the reductive amination route, the Leuckart reaction, and the nitropropene and the bromopropane routes. Based on the structure elucidation of impurities — especially those so-called "route specific" ones — present in these illicit drug preparations conclusions can be drawn about the method of preparation of a drug sample. Furthermore, on the basis of this kind of information methods can be developed for the comparison of drug samples, by which questions about the origin of drug samples can be solved (commonly known as the signature method).

  1. Table of Contents
  2. Introduction
  3. Synthesis Routes
    1. The Reductive Amination Route
    2. The Leuckart Reaction
    3. The Nitropropene Route
    4. The Bromopropane Route
  4. Applications
  5. Conclusion
  6. References
  7. About the Author

I. Introduction

Clandestine manufacturing of 3,4-(methylenedioxy)amphetamine (MDA) analogs and homologs was thoroughly discussed by Dal Cason1. Central nerve system activities, synthesis potentialities, ease of chemical handling, and availability of precursors were reviewed. Achieving synthesis of the desired compounds through the reductive amination route (with several hydrogenation steps), the Leuckart reaction, the bromopropane route, the Ritter reaction, the nitropropene route, and the substituted cinnamic acid route were also focused on1.

As MDA and 3,4-(methylenedioxy)methylamphetamine (MDMA) are nearly always illicitly produced in clandestine laboratories, the preparations produced very often contain precursors, intermediates, or other impurities in addition to the targeted drugs. In fact, the presence of these contaminations derived from different origins in MDA or MDMA preparations can assist in establishing the route of synthesis2 adopted by the individuals illegally producing these amphetamines.

Structure elucidation of the impurities in MDA and MDMA preparations by mass spectrometric and other methods can be found in literature: the reductive amination route3,4, the Leuckart reaction4,5, the nitropropene route5,6, and the bromopropane route7,8. In this article the MS data of the impurities present in preparations of MDA and MDMA are collected and arranged in tables, in according to the synthetic routes used.


II. Synthesis Routes

Scheme 1
Reductive amination

A. The Reductive Amination Route

The most frequently used method to prepare MDMA in The Netherlands can be described as a low pressure reductive amination at slightly elevated temperatures3,4 (Scheme 1).

The structural information and eight-peak MS data of the impurities that are reported for this route of synthesis are summarized in Table 1. The compounds given in the table include starting materials and their impurities, hydrogenated compounds originating from starting materials, and nitrogen-containing compounds - intermediate substances resulting from the reaction of phenylpropanone with impurities in methylamine such as ammonia and higher alkylated amines.

Scheme 2
Leuckart reaction

Besides these impurities relating to chemical synthesis and the substances used in it, the MDA and the MDMA preparations can be contaminated by a host of strange compounds4 including caffeine, cocaine, ketamine, quinine, and amphetamine; the latter substance also contains typical impurities aziridines, pyrimidines, and di-(β-phenylisopropyl)amine.


B. The Leuckart Reaction

This reaction is seldom used for the synthesis of the substituted amphetamines4,5. Using safrole as a starting compound in order to produce the phenylpropanone, the reaction can be schematically depicted as shown in Scheme 2.

The structural information and eight-peak MS data of the impurities that are reported for this route of synthesis are summarized in Table 2. Again, many impurities derive from starting materials and accompanying chemicals; others originate from condensations between the starting material and the end product.

Scheme 3
Nitropropene route


C. The Nitropropene Route

The condensation reaction (Scheme 3) between nitroethane and piperonal has been adopted for the production of MDA5,6.

The structural information and eight-peak MS data of the reported impurities that are known for this route of synthesis are summarized in Table 3. Again, the presence of impurities in the starting materials was noticed, while the most of the other impurities found can best be explained by assuming condensation reactions between starting materials, intermediate, and final products.


D. The Bromopropane Route

Scheme 4
Bromopropane route

The reaction of safrole (obtained from sassafras oil) with hydrobromic acid shown in Scheme 4 was intensively studied7,8.

All bromination products of the other essential oils associated with the starting chemical safrole can be found in MDA or MDMA preparations, depending on the extent of purification attained by the individuals that are producing the illicit drugs. The structural information and eight-peak MS data of the impurities that are reported for this route of synthesis are summarized in Table 4. The impurities given here refer to various compounds present in safrole; the brominated products of these substances resulting from the reaction of different compounds in safrole with hydrobromic acid; and the amino compounds originating from the amination of the bromine-containing substances.


III. Applications

The information collected in the tables was used in the author's laboratory4 to differentiate between the various routes of synthesis followed for the production of MDMA samples. During the past year, very limited use of the data from the tables was made in cases in which the origin of different samples was questioned. These so-called "signature investigations" which utilize gas chromatographic profiles are now in a mature state of development. They are often used in cases in which amphetamine was involved. In particular, Strömberg's group at Linkoping University has reported signatures of amphetamines of different origins for many years9-12. The literature13-15 provides more of an overview of the subject. It stands to reason that the information from the tables can be used for similar purposes, depending on the popularity and future availability of these kinds of drugs.

Impurities found in MDMA synthesized with the reductive amination
1
4-Methyl-1,2-(methylenedioxy)benzene
2
3,4-(Methylenedioxy)benzaldehyde, piperonal
3a
4-Allyl-1,2-(methylenedioxy)benzene, safrole
3b
1,2-(Methylenedioxy)-4-propenylbenzene, isosafrole
4
1,2-(Methylenedioxy)-4-propylbenzene
5
3,4-(Methylenedioxy)benzyl-N-methylamine
6
3,4-(Methylemedioxy)phenylpropanone
7
1,2-(Dimethoxy)-4-propenylbenzene
8
1,2-Methylenedioxy-4-(2-aminopropyl)benzene, 3,4-methylenedioxyamphetamine, MDA
9
1-(3,4-Methylenedioxy)phenylpropanol-2
10
1,2-(Methylenedioxy)-4-(2-N-methyliminopropyl)benzene
11
N-Methyl-[1,2-(methylenedioxy)-4-(2-aminopropyl)]benzene,
3,4-(methylenedioxy)methylamphetamine, MDMA, Ecstasy
12
N,N-Dimethyl-[1,2-(methylenedioxy)-4-(2-aminopropyl)]benzene
13
N-Ethyl,N-methyl-[1,2-(methylenedioxy)-4-(2-aminopropyl)]benzene
Impurities found in MDA synthesized with the Leuckart reaction
1a
4-Allyl-1,2-(methylenedioxy)benzene, safrole
1b
1,2-(Methylenedioxy)-4-propenylbenzene, isosafrole
2
1,2-(Methylenedioxy)-4-propylbenzene
3
3,4-(Methylenedioxy)phenylpropanone
4
Isosafrole glycol
5
N-Formyl MDA
6
Di-[1-(3,4-methylenedioxy)phenyl-2-propyl]amine
7
Di-[1-(3,4-methylenedioxy)phenyl-2-propyl]methylamine
Impurities found in MDA synthesized with the nitropropene route
1
Hydroxyskatole
2
3,4-(Methylenedioxy)benzaldehyde, piperonal
3
3,4-(Methylenedioxy)phenylmethanol
4
3,4-(Methylenedioxy)phenylpropanone
5
3,4-(Methylenedioxy)benzylmethylketoxime
6
1-[3,4-(Methylenedioxy)phenyl]-2-nitro-1-propene
7
N-[β-(3,4-Methylenedioxy)phenylmethyl]-3,4-(methylenedioxy)benzaldimine
8
N,N-Di-[3,4-(Methylenedioxy)phenylmethyl]amine
9
Di-[3,4-(methylenedioxy)phenylpropanone]
10
N-(β-[3,4-(Methylenedioxy)]phenylisopropyl)-3,4-(methylenedioxy)benzaldimine
11
N-(β-[3,4-(Methylenedioxy)]phenylisopropyl)-3,4-(methylenedioxy)benzylketimine
Impurities found in MDA or MDMA synthesized with the bromopropane reaction
1
1,7,7-Trimethylbicyclo(2,2,1)heptan-2-one, Camphor
2a
4-Allyl-1,2-(methylenedioxy)benzene, safrole
2b
1,2-(Methylenedioxy)-4-propenylbenzene, isosafrole
3a
2-Methoxy-4-(2-propenyl)phenol, eugenol
3b
2-Methoxy-4-propenylphenol, isoeugenol
4a
4-Allyl-1,2-(dimethoxy)benzene
4b
1,2-(Dimethoxy)-4-propenylbenzene
5
1-(3,4-Methylenedioxy)phenylpropanol-2
6a
N-Methyl-[1,2-(methylenedioxy)-4-(2-aminopropyl)]benzene,
3,4-(methylenedioxy)methylamphetamine, MDMA, Ecstasy
6b
N-Methyl-[1,2-(methylenedioxy)-4-(3-aminopropyl)]benzene
7
1-(3,4-Methylenedioxy)phenyl-2-methoxypropane
8
N-Methyl-1-[1-(hydroxy)-2-(methoxy)]-4-(2-aminopropyl)]benzene
9
4-Allyl-1,2,3-trimethoxybenzene
10
N-Methyl-1-[1,2-(dimethoxy)-4-(2-aminopropyl)]benzene
11a
1-[3,4-(Methylenedioxy)]-4-(2-bromopropyl)]benzene
11b
1-[3,4-(Methylenedioxy)]-4-(3-bromopropyl)]benzene
12
2-Methoxy-4-(2-bromopropyl)phenol
13a
1,2-Dimethoxy-4-(2-bromopropyl)benzene
13b
1,2-Dimethoxy-4-(3-bromopropyl)benzene
14
1,2,3-Trimethoxy-4-(2-bromopropyl)benzene

IV. Conclusion

Mass spectral information in the tables is given about the different impurities found in either MDA or MDMA preparations that are produced along several routes. In most cases the nature of the impurities can be ascribed to starting chemicals, intermediates, and substances originating from condensations of reaction products in the various stages of the reaction. Some impurities are route specific, e.g., N-formyl MDA, 1-[3,4-(methylenedioxy)phenyl]-2-nitro-1-propene, and the bromo compounds of the bromopropane route. Although there are other possible synthetic routes, only those the impurities of which are described in the literature, are reviewed in this article. In our opinion, proper use of information in the tables can assist in elucidating the nature of a reaction route that may be used for producing an MDA analog preparation.


References

  1. Dal Cason TA: An evaluation of the potential for clandestine manufacture of 3,4-methylenedioxyamphetamine (MDA) analogs and homologs; J. Forensic Sci. 35, 675 (1990)
  2. Verweij AMA: Impurities in illicit drug preparations: amphetamine and methamphetamine; Forensic Sci. Rev. 1, 1-11 (1989)
  3. Verweij AMA: Clandestine manufacture of 3,4-methylenedioxymethylamphetamine (MDMA) by low pressure reductive amination. A mass spectrometric study of some reaction mixtures; Forensic Sci. Int. 45, 91 (1990)
  4. Verweij AMA: Basische Verunreinigungen in auf dem Drogenmarkt käuflichen 3,4-(Methylendioxy)methylamphetamin; Arch. Kriminol. 188, 154 (1991)
  5. Lukaszewski T: Spectroscopic and chromatographic identification of precursors, intermediates, and impurities of 3,4-methylenedioxyamphetamine synthesis; J. Assoc. Off. Anal. Chem. 61, 951 (1978)
  6. Verweij AMA: Verunreinigungen die bei der Herstellung von 3,4-Methylendioxyamphetamin (MDA) durch Kondensation zwischen Nitroethan und Piperonal aufgefunden waren; Arch. Kriminol. 190, 24 (1992)
  7. Noggle FT Jr, Clark RC, DeRuiter J: Gas chromatographic and mass spectrometric analysis of samples from a clandestine laboratory involved in the synthesis of ecstacy from sassafras oil; J. Chromatogr. Sci. 29, 168 (1991)
  8. Noggle FT Jr, Clark RC, DeRuiter J: Gas chromatographic and mass spectrometric analysis of N-methyl-1-aryl-2-propanamines synthesized from the substituted allylbenzenes present in sassafras oil; J. Chromatogr. Sci. 29, 267 (1991)
  9. Alm S, Granstam I, Jonston S, Strömberg L: Classification of Illegal Leuckart Amphetamine by Gas Chromatographic Profiling, Rep. 25, Center of Forensic Science, Linköping University: Linköping, Sweden; 1992.
  10. Kronstrand R: The Conditions of the First Step of the Leuckart Synthesis of Amphetamine and Their Influence on the Impurity Profile, Rep. 22, Center of Forensic Science, Linköping University: Linköping, Sweden; 1990.
  11. Strömberg L, Maehly AC: Advances in Chemical Signature Analysis of Drugs, Center of Forensic Science, Linköping University: Linkoping, Sweden; 1979.
  12. Strömberg L: Comparative gas chromatographic analysis of narcotics. Part II. Amphetamine sulphate; J. Chromatogr. 106, 335 (1975)
  13. Sanger DG, Humphreys U, Patel AC, Japp M, Osborne RGL: The significance of gas chromatographic impurity patterns obtained from illicitly produced amphetamine; Forensic Sci. Int. 28, 7 (1985)
  14. Lambrechts M, Rasmussen KE: Use of bonded phase silica sorbents for rapid sampling of impurities in illicit amphetamine for high performance chromatographic analysis; J. Chromatogr. 331, 339 (1985)
  15. Lambrechts M, Tonnesen F, Rasmussen KE: Profiling of impurities in illicit amphetamine samples by high performance liquid chromatography using column switching; J. Chromatogr. 369, 365 (1986)

About the Author

A. M. A. Verweij

Dr. Anthonie M. A. Verweij is senior chemist in the mass spectrometric service group of the Department of General Chemistry at the Forensic Science Laboratory of the Ministry of Justice at Rijswijk. He studied chemistry at the Free University of Amsterdam, where he received his Ph.D. in organic chemistry in 1970. His current research interests center on studies of the synthesis of illicitly prepared drugs, structural elucidation of impurities found in them, and the application of liquid chromatography/mass spectrometry in forensic science.